Company Announcements

MONTREAL , Oct. 22, 2024 /CNW/ - The Good Shroom Co Inc. (TSXV: MUSH), an emerging cannabis company, announces the launch of DYP's, an innovative THC-infused pouch product, in Alberta, Canada's second-largest cannabis market. The Good Shroom Co operates a portfolio of brands in Quebec, where it sells a wide range of products. The introduction of DYP's is a key component of the company's national expansion strategy.

DYP's are discreet, easy-to-use pouches designed to be placed between the lip and gum, delivering 10mg of THC per pouch, the maximum legal dose. This product is the first of its kind in Canada, offering consumers a smoke-free, affordable, and convenient way to consume THC. The product is arriving in Alberta this week, with distribution scheduled to begin next week.

The decision to launch DYP's is driven by three key factors:

• Discreet and Familiar: DYP's resemble popular nicotine pouches like Zyn and Zonnic which are well established in Canada, making them a familiar option for consumers. The format is discreet and easy to use, offering an alternative to more traditional cannabis consumption methods.
• Competitive Pricing: At a retail price of approximately $20 per unit (10 pouches per unit), DYP's offer consumers an affordable way to consume THC, with each 10mg dose priced around $2.
• First-to-Market Advantage: DYP's are the first THC-infused pouches available in Canada, positioning The Good Shroom Co at the forefront of this new category in the cannabis market.

The pouches will initially be available in two flavors, Wintergreen and Honeydew, with additional flavors planned for Ontario in early 2025. As new opportunities arise in other provinces, the company plans to expand distribution nationwide.

"We are thrilled to bring DYP's to market in Alberta," said Eric Ronsse, CEO of The Good Shroom Co Inc. "This product launch represents an important milestone for our company and for the Canadian cannabis market. DYP's offer consumers a convenient, affordable, and familiar way to consume THC, and we believe the strong feedback from our sales team demonstrates the potential of this new category."

The Good Shroom Co's sales team has been actively engaging retailers to create awareness around the product, and initial feedback has been overwhelmingly positive.

Product Highlights:

• Discreet THC-infused pouches, placed between the lip and gum
• 10mg of THC per pouch, the maximum legal dose
• Available in Wintergreen and Honeydew flavors
• Retail price: ~ $20 per unit (10 pouches per unit)
• Launching in Alberta with plans for expansion into Ontario in 2025

The Good Shroom Co Inc. operates primarily in Quebec, where it manages a portfolio of brands that offer a range of cannabis products. DYP's are the company's first major expansion outside Quebec, forming a key part of its national growth strategy.

About The Good Shroom Co Inc.

The Good Shroom Co Inc. is a publicly traded company (TSX.V: MUSH) specializing in cannabis and wellness products. The company focuses on developing innovative cannabis products that meet consumer needs across Canada.

Website: www.thegoodshroom.co

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Exchange) accepts responsibility for the adequacy or accuracy of this release.

Cautionary Note Regarding Forward-Looking Information

This press release contains statements which constitute "forward-looking statements" and "forward-looking information" within the meaning of applicable securities laws, including statements regarding the plans, intentions, beliefs and current expectations of the Corporation with respect to future business activities and sales, including the anticipated orders to be placed by the SQDC. Forward-looking statements are often identified by the words "may", "would", "could", "should", "will", "intend", "plan", "anticipate", "believe", "estimate", "expect" or similar expressions. Investors are cautioned that forward-looking statements are not based on historical facts but instead reflect the Corporation's expectations, estimates or projections concerning future results or events based on the opinions, assumptions and estimates of management considered reasonable at the date the statements are made. Although the Corporation believes that the expectations reflected in such forward-looking statements are reasonable, such statements involve risks and uncertainties, and undue reliance should not be placed thereon, as unknown or unpredictable factors could have material adverse effects on future results, performance or achievements. Among the key factors that could cause actual results to differ materially from those projected are the following: market acceptance of the Company's hash and other cannabis products, changes in the vendor's business or strategy, changes in our supplier's operations and pricing, expectations regarding competition and their pricing strategy; maintaining in good standing all necessary regulatory licenses and authorizations for its products; the benefits, safety, efficacy, dosing and social acceptance of cannabis related products and no material changes in the legal environment; changes in applicable laws and regulations compliance with extensive government regulation; operational risks related to supply chain disruptions and shortages. Should one or more of these risks or uncertainties materialize, or should assumptions underlying the forward-looking statements prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected. Although the Company has attempted to identify important risks, uncertainties and factors which could cause actual results to differ materially, there may be others that cause results not to be as anticipated, estimated or intended and such changes could be material. The Company does not intend, and do not assume any obligation, to update the forward-looking statements except as otherwise required by applicable law. Trading in the securities of the Company should be considered highly speculat ive.

SOURCE Good Shroom Co Inc. (The)